Les critères d'utilisation de la carboxypeptidase dans les surexpositions au méthotrexate doivent être mieux définis
Thérapie, 63 1 (2008) 19-28
Published online: 2008-04-04
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Extracorporeal Treatment for Methotrexate Poisoning
Marc Ghannoum, Darren M. Roberts, David S. Goldfarb, Jesper Heldrup, Kurt Anseeuw, Tais F. Galvao, Thomas D. Nolin, Robert S. Hoffman, Valery Lavergne, Paul Meyers, Sophie Gosselin, Tudor Botnaru, Karine Mardini and David M. WoodClinical Journal of the American Society of Nephrology 17 (4) 602 (2022)
https://doi.org/10.2215/CJN.08030621
A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy
Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.Analytical Methods 6 (1) 178 (2014)
https://doi.org/10.1039/c3ay40815a
A fast LC-MS/MS assay for methotrexate monitoring in plasma: validation, comparison to FPIA and application in the setting of carboxypeptidase therapy
Régis Bouquié, Guillaume Deslandes, Blanca Nieto Bernáldez, et al.Anal. Methods 6 (1) 178 (2014)
https://doi.org/10.1039/C3AY40815A
Niveau de preuve du suivi thérapeutique pharmacologique du méthotrexate au décours de son administration à haute-dose
Chantal Le Guellec, Hélène Blasco, Isabelle Benz and Anne HulinThérapie 65 (3) 163 (2010)
https://doi.org/10.2515/therapie/2010016